Company Comparison
Blueprint Medicines vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Blueprint Medicines | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | San Diego |
| Founded | 2011 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $676M | $48M |
| Valuation | — | — |
What They Build
Blueprint Medicines
Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Blueprint Medicines
AI Therapeutics
No investors listed.
Sector Overlap
Both Blueprint Medicines and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.